Mikhail Kvasnikov, CEO of Pharmasyntez-Nord, has been ranked among the top three senior executives in St. Petersburg's pharmaceutical manufacturing sector, according to the annual TOP-100 rating published by Delovoi Peterburg (Business Petersburg).

Kvasnikov earned his place in the ranking on the strength of the company's operational and financial performance. By the end of 2025, Pharmasyntez-Nord's share of the Russian pharmaceutical market in its core product categories reached 27%. The company continues to deliver strong, sustained growth: sales volumes exceeded 6 million packages, with consistent year-over-year expansion.

In parallel, Pharmasyntez-Nord has been rolling out advanced technological solutions aimed at boosting operational efficiency. These initiatives enable the company to maintain steady growth momentum and preserve its competitive standing even amid shifting market conditions.

The TOP-100 ranking traditionally recognizes industry leaders who drive strong economic results and make a tangible contribution to the development of their respective sectors.

We extend our congratulations to the entire Pharmasyntez-Nord team on this well-deserved achievement!